{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:55:11Z","timestamp":1791640511244,"version":"4.3.4"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi260159-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Anemia has been associated with increased dementia risk, but its relationship with Alzheimer disease (AD) blood biomarkers remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260159-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate whether there is a cross-sectional association between hemoglobin and AD blood biomarker levels and a longitudinal association of hemoglobin and AD biomarkers with incident dementia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260159-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This cohort study used data from the Swedish National Study on Aging and Care in Kungsholmen (SNAC-K), a longitudinal population-based study. Randomly selected adults aged 60 years or older were enrolled at baseline (March 21, 2001, to August 30, 2004) and followed up every 3 or 6 years according to age through December 31, 2019. Data analysis was conducted between September 1, 2024, and January 7, 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260159-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Hemoglobin level measured at baseline. Anemia was defined according to World Health Organization criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260159-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>\n                      Incident dementia, diagnosed according to\n                      <jats:italic toggle=\"yes\">Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition<\/jats:italic>\n                      (\n                      <jats:italic toggle=\"yes\">DSM-IV<\/jats:italic>\n                      ) criteria, and serum concentrations of phosphorylated tau 217 (p-tau217), neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP), measured using Simoa assays. Cox proportional hazards regression and quantile regression models were used to examine the association of hemoglobin with dementia risk and AD blood biomarkers. The joint association of hemoglobin and AD blood biomarkers with dementia development using Cox proportional hazards regression was also explored.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260159-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 3363 adults were enrolled in SNAC-K (73.3% participation rate). After excluding those with dementia or missing AD biomarkers or hemoglobin measures, 2282 dementia-free participants were included in the current study (median age, 72.2 [IQR, 60.8-81.1] years; 1406 [61.6%] female). During a mean (SD) follow-up of 9.3 (4.3) years, 362 participants (15.9%) developed dementia. Compared with individuals with a normal hemoglobin level, those with anemia had higher baseline levels of p-tau217 (\u03b2, 0.22; 95% CI, 0.15-0.30), NfL (\u03b2, 0.25; 95% CI, 0.19-0.31), and GFAP (\u03b2, 0.08; 95% CI, 0.03-0.12) and showed a higher risk of developing dementia (hazard ratio [HR], 1.66; 95% CI, 1.21-2.28) during follow-up. Participants with both anemia and high p-tau217, NfL, or GFAP had the highest hazard of dementia (eg, adjusted HR of 3.64 [95% CI, 2.39-5.56] among those with anemia and high NfL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260159-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cohort study of dementia-free older adults, anemia was associated cross-sectionally with higher levels of AD blood biomarkers and longitudinally with increased dementia risk. The highest dementia risk occurred when low hemoglobin and elevated AD biomarkers coexisted, suggesting a potential interplay between anemia and neuropathology in dementia development.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.4029","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:30:27Z","timestamp":1776439827000},"page":"e264029","source":"Crossref","is-referenced-by-count":7,"title":["Anemia and Blood Biomarkers of Alzheimer Disease in Dementia Development"],"prefix":"10.1001","volume":"9","author":[{"given":"Martina","family":"Valletta","sequence":"first","affiliation":[{"name":"Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide Liborio","family":"Vetrano","sequence":"additional","affiliation":[{"name":"Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden"},{"name":"Stockholm Gerontology Research Center, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxuan","family":"Qiu","sequence":"additional","affiliation":[{"name":"Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Canevelli","sequence":"additional","affiliation":[{"name":"Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden"},{"name":"Department of Human Neuroscience, Sapienza University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Miccoli","sequence":"additional","affiliation":[{"name":"Department of Human Neuroscience, Sapienza University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Andersson","sequence":"additional","affiliation":[{"name":"Affinity Proteomics Stockholm, Science for Life Laboratory, Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), Royal Institute of Technology (KTH), Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Fredolini","sequence":"additional","affiliation":[{"name":"Affinity Proteomics Stockholm, Science for Life Laboratory, Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), Royal Institute of Technology (KTH), Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Bruno","sequence":"additional","affiliation":[{"name":"Department of Human Neuroscience, Sapienza University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Winblad","sequence":"additional","affiliation":[{"name":"Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden"},{"name":"Theme Inflammation and Aging, Karolinska University Hospital, Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fratiglioni","sequence":"additional","affiliation":[{"name":"Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Grande","sequence":"additional","affiliation":[{"name":"Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden"},{"name":"Stockholm Gerontology Research Center, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"issue":"8","key":"zoi260159r1","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1182\/blood-2004-05-1812","article-title":"Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia.","volume":"104","author":"Guralnik","year":"2004","journal-title":"Blood"},{"issue":"1","key":"zoi260159r2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/ageing\/afaa178","article-title":"Anaemia and physical and mental health in the very old: an individual participant data meta-analysis of four longitudinal studies of ageing.","volume":"50","author":"Palapar","year":"2021","journal-title":"Age Ageing"},{"issue":"9","key":"zoi260159r3","doi-asserted-by":"publisher","first-page":"e917","DOI":"10.1212\/WNL.0000000000008003","article-title":"Hemoglobin and anemia in relation to dementia risk and accompanying changes on brain MRI.","volume":"93","author":"Wolters","year":"2019","journal-title":"Neurology"},{"issue":"6","key":"zoi260159r4","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1212\/WNL.0b013e31829e701d","article-title":"Anemia and risk of dementia in older adults: findings from the Health ABC study.","volume":"81","author":"Hong","year":"2013","journal-title":"Neurology"},{"issue":"9","key":"zoi260159r5","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1111\/ene.12175","article-title":"Anaemia and cognitive performances in the elderly: a systematic review.","volume":"20","author":"Andro","year":"2013","journal-title":"Eur J Neurol"},{"key":"zoi260159r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101343","article-title":"Hypoxia and brain aging: neurodegeneration or neuroprotection?","volume":"68","author":"Burtscher","year":"2021","journal-title":"Ageing Res Rev"},{"issue":"2","key":"zoi260159r7","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3233\/JAD-201386","article-title":"Red cell distribution width, anemia, and brain volumetric outcomes among middle-aged adults.","volume":"81","author":"Beydoun","year":"2021","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"zoi260159r8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s12883-021-02487-z","article-title":"Anaemia and cerebrospinal fluid biomarkers of Alzheimer\u2019s pathology in cognitively normal elders: the CABLE study.","volume":"21","author":"Yang","year":"2021","journal-title":"BMC Neurol"},{"issue":"1","key":"zoi260159r9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation.","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol"},{"issue":"1","key":"zoi260159r10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13195-025-01919-z","article-title":"Fluid biomarkers for neurodegenerative diseases: a comprehensive update.","volume":"18","author":"Valletta","year":"2025","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"zoi260159r11","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1038\/s41591-025-03605-x","article-title":"Blood-based biomarkers of Alzheimer\u2019s disease and incident dementia in the community.","volume":"31","author":"Grande","year":"2025","journal-title":"Nat Med"},{"issue":"6","key":"zoi260159r12","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1002\/alz.13860","article-title":"Blood biomarkers of Alzheimer\u2019s disease in the community: variation by chronic diseases and inflammatory status.","volume":"20","author":"Valletta","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"2","key":"zoi260159r13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/BF03324546","article-title":"A longitudinal study integrating population, care and social services data: the Swedish National Study on Aging and Care (SNAC).","volume":"16","author":"Lagergren","year":"2004","journal-title":"Aging Clin Exp Res"},{"issue":"9596","key":"zoi260159r14","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"8","key":"zoi260159r16","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1176\/ajp.152.8.1228","article-title":"Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV).","volume":"152","author":"Guze","year":"1995","journal-title":"Am J Psychiatry"},{"issue":"1","key":"zoi260159r17","doi-asserted-by":"publisher","first-page":"10412","DOI":"10.1038\/s41467-025-66728-2","article-title":"Blood biomarkers of Alzheimer\u2019s disease and progression across different stages of cognitive decline in the community.","volume":"16","author":"Valletta","year":"2025","journal-title":"Nat Commun"},{"issue":"10","key":"zoi260159r18","first-page":"1417","article-title":"Assessing and measuring chronic multimorbidity in the older population: a proposal for its operationalization.","volume":"72","author":"Calder\u00f3n-Larra\u00f1aga","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"zoi260159r19","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/alz.12466","article-title":"Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities.","volume":"18","author":"Syrjanen","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"9","key":"zoi260159r20","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1002\/alz.13088","article-title":"Associations of blood cell indices and anemia with risk of incident dementia: a prospective cohort study of 313?448 participants.","volume":"19","author":"Qiang","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"2","key":"zoi260159r21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.neurobiolaging.2005.02.007","article-title":"Anaemia increases the risk of dementia in cognitively intact elderly.","volume":"27","author":"Atti","year":"2006","journal-title":"Neurobiol Aging"},{"issue":"5","key":"zoi260159r22","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/00019442-200409000-00011","article-title":"Hemoglobin levels and Alzheimer disease: an epidemiologic study in India.","volume":"12","author":"Pandav","year":"2004","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"zoi260159r23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1212\/WNL.0b013e318225aaa9","article-title":"Hemoglobin level in older persons and incident Alzheimer disease: prospective cohort analysis.","volume":"77","author":"Shah","year":"2011","journal-title":"Neurology"},{"issue":"12","key":"zoi260159r24","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1159\/000522500","article-title":"Association of anemia with dementia and cognitive decline among community-dwelling elderly.","volume":"68","author":"Weiss","year":"2022","journal-title":"Gerontology"},{"issue":"3","key":"zoi260159r25","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3233\/JAD-190521","article-title":"Anemia in association with cognitive impairment: a systematic review and meta-analysis.","volume":"72","author":"Kim","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"zoi260159r26","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jalz.2013.05.1771","article-title":"Plasma nutrient status of patients with Alzheimer\u2019s disease: systematic review and meta-analysis.","volume":"10","author":"Lopes da Silva","year":"2014","journal-title":"Alzheimers Dement"},{"issue":"11","key":"zoi260159r27","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S1474-4422(06)70598-1","article-title":"Vitamin B12, folic acid, and the nervous system.","volume":"5","author":"Reynolds","year":"2006","journal-title":"Lancet Neurol"},{"issue":"1-2","key":"zoi260159r28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jns.2014.07.062","article-title":"Dementia is associated with iron-deficiency anemia in females: a population-based study.","volume":"346","author":"Chung","year":"2014","journal-title":"J Neurol Sci"},{"key":"zoi260159r29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12882-016-0226-6","article-title":"Anemia and risk for cognitive decline in chronic kidney disease.","volume":"17","author":"Kurella Tamura","year":"2016","journal-title":"BMC Nephrol"},{"issue":"8","key":"zoi260159r30","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup.","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"8","key":"zoi260159r31","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209219","article-title":"Explaining the variability of Alzheimer disease fluid biomarker concentrations in memory clinic patients without dementia.","volume":"102","author":"Bouteloup","year":"2024","journal-title":"Neurology"},{"key":"zoi260159r32","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.625511","article-title":"Blood hemoglobin, in-vivo Alzheimer pathologies, and cognitive impairment: a cross-sectional study.","volume":"13","author":"Kim","year":"2021","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"zoi260159r33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13024-024-00719-7","article-title":"The concept of resilience to Alzheimer\u2019s disease: current definitions and cellular and molecular mechanisms.","volume":"19","author":"de Vries","year":"2024","journal-title":"Mol Neurodegener"},{"issue":"6","key":"zoi260159r34","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41582-022-00642-9","article-title":"Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes.","volume":"18","author":"G\u00f3mez-Isla","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"zoi260159r35","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.neurobiolaging.2014.12.019","article-title":"Hemoglobin, hematocrit, and changes in cerebral blood flow: the Second Manifestations of ARTerial Disease\u2013Magnetic Resonance study.","volume":"36","author":"van der Veen","year":"2015","journal-title":"Neurobiol Aging"},{"issue":"1","key":"zoi260159r36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13045-021-01202-2","article-title":"Burden of anemia and its underlying causes in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019.","volume":"14","author":"Safiri","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"9","key":"zoi260159r37","doi-asserted-by":"publisher","first-page":"e713","DOI":"10.1016\/S2352-3026(23)00160-6","article-title":"Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990-2021: findings from the Global Burden of Disease Study 2021.","volume":"10","author":"GBD 2021 Anaemia Collaborators","year":"2023","journal-title":"Lancet Haematol"},{"key":"zoi260159r38","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.1016\/j.amjmed.2003.12.009","article-title":"Prevalence and outcomes of anemia in geriatrics: a systematic review of the literature.","volume":"116","author":"Begh\u00e9","year":"2004","journal-title":"Am J Med"},{"issue":"8","key":"zoi260159r39","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1111\/trf.15338","article-title":"Greater anemia tolerance among hospitalized females compared to males.","volume":"59","author":"Visagie","year":"2019","journal-title":"Transfusion"},{"issue":"7","key":"zoi260159r40","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.70114","article-title":"Equivalence of plasma and serum for clinical measurement of p-tau217: comparative analyses of four blood-based assays.","volume":"169","author":"Chen","year":"2025","journal-title":"J Neurochem"},{"issue":"2","key":"zoi260159r41","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/clinchem\/hvaf162","article-title":"Diagnostic value of serum p-tau217 in Alzheimer disease: equal to plasma in levels and clinical utility?","volume":"72","author":"Benedet","year":"2026","journal-title":"Clin Chem"},{"key":"zoi260159r15","unstructured":"World Health Organization. Guideline on Haemoglobin Cutoffs to Define Anaemia in Individuals and Populations. World Health Organization; 2024. Accessed December 29, 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK602198\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2847873\/valletta_2026_oi_260159_1775848023.49226.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:30:29Z","timestamp":1776439829000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2847873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.4029","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]}}}